I. The Mechanisms of Action of GLP-1
For several years, GLP-1 analogues have been increasingly used in the management of patients with type II diabetes or obesity, with a growing number of molecules on the market. GLP-1, for Glucagon-Like Peptide-1, is a molecule naturally and continuously secreted by cells in...
Bariatric surgery doesn't end when the patient leaves the operating room. Nor does it start at the moment of anesthesia. Its true beginning is weeks before, in metabolic preparation, and its long-term success is defined in the following months, with a follow-up that goes far beyond the weight on...
Introduction
Multi-frequency bioimpedance has emerged as a revolutionary technology in the field of public health, offering a precise and non-invasive evaluation of body composition. Aminogram, a leading company in the development of multi-frequency bioimpedance devices, has designed tools that not only improve prevention and diagnosis but also optimize the monitoring...
Gildardo Uribe GilND- MgSC, Phd (c) en SP
Obesity is a complex condition that affects millions of people worldwide, with WHO projections indicating that approximately 4 billion adults will be living with overweight or obesity by 2030. In addition to metabolic and cardiovascular impacts, excess body fat is associated with...
According to a recent expert consensus¹, obesity is defined as a condition characterized by a body mass index (BMI) greater than 30 kg/m², combined with excess fat mass that leads to clinical complications impairing the patient’s health. From a pathophysiological perspective, this excess fat mass causes low-grade systemic inflammation...